Emzadirib

N/A

Report date: 2025/03/14 11:06:35
NME

Base Information

Drug NameEmzadirib
Drug Alias NameCYT-0851
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA repair protein RAD51 homolog 1 inhibitors
TargetsDNA repair protein RAD51 homolog 1
Therapy Area/IndicationsSmall Cell Lung CarcinomaHead and Neck NeoplasmsOvarian Neoplasms +[15] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCyteir Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCyteir Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaHead and Neck NeoplasmsOvarian Neoplasms +[14] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A